Moons AH - Search Results

1

The impact on coagulation of an intravenous loading dose in addition to a subcutaneous regimen of low-molecular-weight heparin in the initial treatment of acute coronary syndromes.

Bijsterveld NR, Moons AH, Meijers JC, Levi M, Büller HR, Peters RJ. Bijsterveld NR, et al. Among authors: moons ah. J Am Coll Cardiol. 2003 Aug 6;42(3):424-7. doi: 10.1016/s0735-1097(03)00653-3. J Am Coll Cardiol. 2003. PMID: 12906966 Free article. Clinical Trial.

2

Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin.

Bijsterveld NR, Moons AH, Meijers JC, Tijssen JG, Büller HR, Levi M, Peters RJ. Bijsterveld NR, et al. Among authors: moons ah. J Am Coll Cardiol. 2002 Mar 6;39(5):811-7. doi: 10.1016/s0735-1097(01)01825-3. J Am Coll Cardiol. 2002. PMID: 11869846 Free article. Clinical Trial.

3

Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers.

Bijsterveld NR, Moons AH, Boekholdt SM, van Aken BE, Fennema H, Peters RJ, Meijers JC, Büller HR, Levi M. Bijsterveld NR, et al. Among authors: moons ah. Circulation. 2002 Nov 12;106(20):2550-4. doi: 10.1161/01.cir.0000038501.87442.02. Circulation. 2002. PMID: 12427650 Clinical Trial.

4

Recombinant nematode anticoagulant protein c2, a novel inhibitor of tissue factor-factor VIIa activity, abrogates endotoxin-induced coagulation in chimpanzees.

Moons AH, Peters RJ, Cate Ht, Bauer KA, Vlasuk GP, Büller HR, Levi M. Moons AH, et al. Thromb Haemost. 2002 Oct;88(4):627-31. Thromb Haemost. 2002. PMID: 12362234

5

Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplasty.

Moons AH, Peters RJ, Bijsterveld NR, Piek JJ, Prins MH, Vlasuk GP, Rote WE, Büller HR. Moons AH, et al. J Am Coll Cardiol. 2003 Jun 18;41(12):2147-53. doi: 10.1016/s0735-1097(03)00478-9. J Am Coll Cardiol. 2003. PMID: 12821239 Free article. Clinical Trial.

6

Recombinant nematode anticoagulant protein c2, an inhibitor of tissue factor/factor VIIa, attenuates coagulation and the interleukin-10 response in human endotoxemia.

de Pont AC, Moons AH, de Jonge E, Meijers JC, Vlasuk GP, Rote WE, Büller HR, van der Poll T, Levi M. de Pont AC, et al. Among authors: moons ah. J Thromb Haemost. 2004 Jan;2(1):65-70. doi: 10.1111/j.1538-7836.2004.00526.x. J Thromb Haemost. 2004. PMID: 14717968 Free article. Clinical Trial.

7

Tissue factor and coronary artery disease.

Moons AH, Levi M, Peters RJ. Moons AH, et al. Cardiovasc Res. 2002 Feb 1;53(2):313-25. doi: 10.1016/s0008-6363(01)00452-7. Cardiovasc Res. 2002. PMID: 11827681 Review.

8

Platelet function and coronary artery disease.

Peters RJ, Moons AH. Peters RJ, et al. Among authors: moons ah. Eur J Clin Invest. 2001 Jan;31(1):3-5. doi: 10.1046/j.1365-2362.2001.00783.x. Eur J Clin Invest. 2001. PMID: 11168431 Review. No abstract available.

9

Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review.

Boekholdt SM, Bijsterveld NR, Moons AH, Levi M, Büller HR, Peters RJ. Boekholdt SM, et al. Among authors: moons ah. Circulation. 2001 Dec 18;104(25):3063-8. doi: 10.1161/hc5001.100793. Circulation. 2001. PMID: 11748101

10

Inhibition of the tissue factor pathway of coagulation by recombinant nematode anticoagulant protein c2 during elective coronary stent implantation.

Moons AH, Bijsterveld NR, Koch KT, Meijers JC, Tijssen JG, van der Poll T, Büller HR, Peters RJ. Moons AH, et al. Neth Heart J. 2004 Feb;12(2):48-54. Neth Heart J. 2004. PMID: 25696294 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page